Viral Vyas
- Co-authors
- Eric H. RubinAberra FuraPatrick J. SinkoElora GuptaSusan GoodinW. Griffith HumphreysA. H. CornfieldT. S. Ravikumar
- Topics
- Cancer therapeutics and mechanisms (5 papers)Drug Transport and Resistance Mechanisms (4 papers)Cancer Treatment and Pharmacology (2 papers)
- Partner nations
- United StatesGermanyKuwait
In The Last Decade
Viral Vyas
14 papers receiving 446 citations
Peers
Comparison fields: 5 of 71
- Molecular Biology 271
- Oncology 188
- Endocrinology, Diabetes and Metabolism 72
- Organic Chemistry 54
- Pharmacology 52
Countries citing papers authored by Viral Vyas
This map shows the geographic impact of Viral Vyas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viral Vyas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viral Vyas more than expected).
Fields of papers citing papers by Viral Vyas
This network shows the impact of papers produced by Viral Vyas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viral Vyas. The network helps show where Viral Vyas may publish in the future.
Co-authorship network of co-authors of Viral Vyas
This figure shows the co-authorship network connecting the top 25 collaborators of Viral Vyas. A scholar is included among the top collaborators of Viral Vyas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viral Vyas. Viral Vyas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 86 | |
| 2 | 17 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 24 | |
| 6 | 49 | |
| 7 | 44 | |
| 8 | 54 | |
| 9 | A phase I and pharmacologic study of the combination of marimastat and paclitaxel in patients with advanced malignancy. | 8 |
| 10 | Phase I evaluation of sequential topoisomerase targeting with irinotecan/cisplatin followed by etoposide in patients with advanced malignancy. | 10 |
| 11 | 26 | |
| 12 | The intestinal absorption of camptothecin, a highly lipophilic drug, across Caco-2 cells is mediated by active transporter(s). | 24 |
| 13 | In vitro activation of irinotecan to SN-38 by human liver and intestine. | 50 |
| 14 | 44 | |
| 15 | 21 |
About Viral Vyas
Viral Vyas is a scholar working on Oncology, Molecular Biology and Nephrology, having authored 15 papers that have together received 459 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Oncology (188 citations), Pharmacology (41 citations) and Endocrinology, Diabetes and Metabolism (72 citations). Viral Vyas has collaborated with scholars based in United States, Germany and Kuwait. Frequent co-authors include Eric H. Rubin, Aberra Fura, Patrick J. Sinko, Elora Gupta, Susan Goodin, W. Griffith Humphreys, A. H. Cornfield, T. S. Ravikumar, Lawrence G. Hamann and Lisa J. Christopher. Their work appears in journals such as Journal of Clinical Oncology, Endocrinology and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.